Effects of synthetic human gastrin I on movements on water, electrolytes, and glucose across the human small intestine.

Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man. Gut (1980) 0.80

Mechanisms of control of intestinal transport: a review. J R Soc Med (1984) 0.75

Water and electrolyte absorption from a human Thiry-Vella ileal loop. Responses to systemic administration of gastrin, glucagon, secretin, and cholecystokinin. Ann Surg (1986) 0.75

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

Occurrence of a new microsporidan: Enterocytozoon bieneusi n.g., n. sp., in the enterocytes of a human patient with AIDS. J Protozool (1985) 4.11

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut (1989) 2.89

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41

Gut-hormone profile in coeliac disease. Lancet (1978) 2.25

Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1994) 2.07

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1994) 2.03

Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02

Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood (2001) 1.95

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85

Diarrhoea and malabsorption in acquired immune deficiency syndrome: a study of four cases with special emphasis on opportunistic protozoan infestations. Gut (1985) 1.82

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71

Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology (1998) 1.71

Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70

Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69

Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63

Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology (1983) 1.62

Effect of prostaglandin E 1 on glucose, water, and electrolyte absorption in the human jejunum. Gastroenterology (1973) 1.62

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60

Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2001) 1.58

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut (2005) 1.58

Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease"). Digestion (1968) 1.56

Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood (1998) 1.56

Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol (1997) 1.49

Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48

Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study. Eur J Gastroenterol Hepatol (2001) 1.46

[Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases]. Gastroenterol Clin Biol (1990) 1.44

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44

Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet (1978) 1.41

[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40

Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment. Gut (1999) 1.39

Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39

Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology (1981) 1.39

Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut (1997) 1.38

Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates. Gut (1971) 1.38

The method of intraluminal perfusion of the human small intestine. I. Principle and technique. Digestion (1973) 1.37

Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci (1994) 1.31

Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features. J Infect Dis (1993) 1.30

[Proposal of a system of criteria for the diagnosis of cryptogenetic inflammatory enterocolitis (Crohn's disease and hemorrhagic rectocolitis). A cooperative study by the Cryptogenic Enterocolitis Study Group]. Gastroenterol Clin Biol (1978) 1.30

Planning a reproducibility study: how many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat Med (2001) 1.30

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol (1999) 1.27

Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr (1988) 1.25

Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev (2000) 1.24

Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22

Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood (1993) 1.22

Crohn's disease with respiratory tract involvement. Gut (1987) 1.20

Technical hazards of using nutritive mixtures in bags for cyclical intravenous nutrition: comparison with standard intravenous nutrition in 48 gastroenterological patients. Gut (1982) 1.19

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol (2001) 1.19

Gut hormone release after intestinal resection. Gut (1982) 1.18

[Study of the progression of an ordinary meal in the human small bowel by a scintigraphic method (author's transl)]. Gastroenterol Clin Biol (1979) 1.14

Assessment of the accuracy of segmental perfusion under an occluding balloon for measuring the intrajejunal secretion of albumin and immunoglobulin A. Gut (1981) 1.11

Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci (1985) 1.10

Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09

[Clinical, anatomo-pathological and immunochemical study of a further case of alpha chain disease followed for 5 years]. Rev Eur Etud Clin Biol (1972) 1.08

Allergic granulomatous vasculitis (Churg-Strauss Syndrome). Report of a case with widespread digestive involvement. Dig Dis Sci (1981) 1.07

Amyloidosis associated with primary agammaglobulinemia, severe diarrhea and familial hypogammaglobulinemia. Am J Med (1969) 1.06

Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique. Gut (1984) 1.05

Gut hormones in inflammatory bowel disease. Scand J Gastroenterol (1983) 1.05

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1995) 1.05

Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol (1996) 1.03

Hypercalcitoninaemia in vipomas. Lancet (1978) 1.01

A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr (1997) 1.01

[A further case of alpha chain disease in a Eurasian]. Ann Med Interne (Paris) (1970) 1.01

Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00

[Measurement of gastric transepithelial potential difference. Effect of provocative agents (aspirin, alcohol) and gastric dressings]. Gastroenterol Clin Biol (1985) 1.00

Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. Gastroenterology (1975) 1.00

Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroenterol (1978) 1.00

Acquired immunodeficiency with intestinal cryptosporidiosis: possible transmission by Haitian whole blood. Lancet (1983) 0.98

Jejunal secretory effect of intraduodenal food in humans. A comparison of mixed nutrients, proteins, lipids, and carbohydrates. Gastroenterology (1985) 0.98

Diarrhoea associated with medullary carcinoma of the thyroid. Gut (1969) 0.98

Effect of pectin on jejunal glucose absorption and unstirred layer thickness in normal man. Gut (1984) 0.98

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet (2000) 0.97

Letter: Vitamin B12 malabsorption in chronic pancreatitis. Gastroenterology (1974) 0.97

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol (1996) 0.96

Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96

Hydrostatic balloon dilatation of Crohn's strictures. Aliment Pharmacol Ther (2003) 0.95

Metformin in the digestive tract. Diabetes Res Clin Pract (1988) 0.95

Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption. Br J Clin Pharmacol (1985) 0.95

CARD4/NOD1 is not involved in inflammatory bowel disease. Gut (2003) 0.94

Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94

Gastric emptying and intragastric distribution of lipids in man. A new scintigraphic method of study. Dig Dis Sci (1982) 0.93

European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group. Gastroenterology (1995) 0.92

[Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)]. Gastroenterol Clin Biol (1981) 0.92